Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07476326
What this trial is testing

Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma

Who this might be right for
Melanoma
Biocon Biologics UK PLC 120
Testing effectiveness (Phase 2)Study completedNCT00387751
What this trial is testing

Bevacizumab and Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma

Who this might be right for
Recurrent MelanomaStage III Skin MelanomaStage IV Skin Melanoma
National Cancer Institute (NCI) 14
Not applicableWithdrawnNCT00378781
What this trial is testing

Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection

Who this might be right for
Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT01705392
What this trial is testing

Bevacizumab vs Dacarbazine in Metastatic Melanoma

Who this might be right for
Metastatic Malignant MelanomaUnresectable Malignant Melanoma
Haukeland University Hospital 2
Testing effectiveness (Phase 2)Study completedNCT00383292
What this trial is testing

Tasisulam in Treating Participants With Malignant Melanoma

Who this might be right for
Metastatic Melanoma
Eli Lilly and Company 130
Testing effectiveness (Phase 2)Study completedNCT00089063
What this trial is testing

Vaccine Therapy With or Without Sargramostim in Treating Patients Who Have Undergone Surgery for Melanoma

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+6 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Ended earlyNCT01082887
What this trial is testing

Immunotherapy With TIL (Tumor Infiltrating Lymphocytes) in Combination With Intra-tumoral Injections of Interferon Gamma-adenovirus (Ad-IFNg) in Patients With Stage IIIc or Stage IV Metastatic Melanoma (AJCC)(Protocol TIL-Ad-INFg)

Who this might be right for
Metastatic Melanoma
Nantes University Hospital 18
Large-scale testing (Phase 3)Study completedNCT00091572
What this trial is testing

Temozolomide Versus Dacarbazine in Stage IV Metastatic Melanoma (Study P03267)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 859
Testing effectiveness (Phase 2)Ended earlyNCT00924001
What this trial is testing

Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic Melanoma

Who this might be right for
MelanomaMalignant MelanomaMelanoma, Experimental
National Cancer Institute (NCI) 1
Testing effectiveness (Phase 2)Study completedNCT04330430
What this trial is testing

Neo-adjuvant T-VEC + Nivolumab Combination Therapy for Resectable Early Metastatic (stage IIIB/C/D-IV M1a) Melanoma with Injectable Disease

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
The Netherlands Cancer Institute 24
Not applicableActive Not RecruitingNCT03605771
What this trial is testing

Descriptive Observational Study on the Characteristics of Advanced and Metastatic Melanoma in Spain

Who this might be right for
Melanoma Stage IvMelanoma Stage IiiAdvanced Cancer
Grupo Español Multidisciplinar de Melanoma 400
Large-scale testing (Phase 3)UnknownNCT00039234
What this trial is testing

Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Stage IV Melanoma Metastatic to the Liver

Who this might be right for
Melanoma (Skin)Metastatic Cancer
Maxim Pharmaceuticals
Testing effectiveness (Phase 2)WithdrawnNCT05496192
What this trial is testing

Nivolumab Intravenous (IV) to Subcutaneous (SC) Switch in Adjuvant Melanoma and Bladder Cancer

Who this might be right for
MelanomaUrothelial Carcinoma
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Study completedNCT01124734
What this trial is testing

High Dose Interleukin-2 Followed by Intermittent Low Dose Temozolomide in Patients With Melanoma

Who this might be right for
Malignant Melanoma
Milton S. Hershey Medical Center 17
Very early researchStudy completedNCT04752267
What this trial is testing

18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Glioma+17 more
University of Southern California 10
Not applicableLooking for participantsNCT07302607
What this trial is testing

Predictive Factors of Complete Response to Immunotherapy in Metastatic Melanoma: a Single-center Retrospective Study Between 2013 and 2021

Who this might be right for
Stage III Melanoma
University Hospital, Strasbourg, France 221
Testing effectiveness (Phase 2)Study completedNCT01302496
What this trial is testing

Autologous TriMix-DC Therapeutic Vaccine in Combination With Ipilimumab in Patients With Previously Treated Unresectable Stage III or IV Melanoma

Who this might be right for
Malignant Melanoma Stage IIIMalignant Melanoma Stage IV
Bart Neyns 39
Very early researchStudy completedNCT00580060
What this trial is testing

Injection Of AJCC Stage IIB, IIC, III And IV Melanoma Patients With A Multi-Epitope Peptide Vaccine Using GM-CSF DNA As An Adjuvant: A Pilot Trial To Assess Safety And Immunity

Who this might be right for
Melanoma
Memorial Sloan Kettering Cancer Center 20
Testing effectiveness (Phase 2)Looking for participantsNCT04771520
What this trial is testing

Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8+26 more
M.D. Anderson Cancer Center
Not applicableStudy completedNCT07436390
What this trial is testing

IFN-Gamma Expression as a Predictor of Response to Immune Checkpoint Inhibitors in First-Line Metastatic Melanoma

Who this might be right for
Metastatic MelanomaMalignant MelanomaSkin Cancer
Institute of Oncology Ljubljana 132
Next Page
50